World Leading Antibody Services. Specialists in Discovery to Clinical Supply.
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
12
NCT06674538
Clinical Trial to Treat Stage IV Cancer Patients
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 30, 2024
Completion: Jan 31, 2029
Loading map...